Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

QL1706 Combined With Standard Therapy for Conversion Therapy of Synchronous Liver Metastases From Colon Cancer: a Multicenter, Single-arm, Exploratory Study

NCT07649473 is registered in ClinicalTrials.gov with Fujian Medical University as lead sponsor.

NCT NCT07649473
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07649473 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
QL1706 Combined With Standard Therapy for Conversion Therapy of Synchronous Liver Metastases From Colon Cancer: a Multicenter, Single-arm, Exploratory Study
Lead sponsor
Fujian Medical University
Phase
Phase 2
Overall status
Not yet recruiting
Start date
August 15, 2026
Completion date
December 31, 2033
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colon cancer, synchronous liver metastases